Literature DB >> 29063348

Differential contribution of microglia and monocytes in neurodegenerative diseases.

Caroline Baufeld1, Elaine O'Loughlin1, Narghes Calcagno1, Charlotte Madore1, Oleg Butovsky2,3.   

Abstract

Neuroinflammation is a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Microglia, the innate immune cells of the CNS, are the first to react to pathological insults. However, multiple studies have also demonstrated an involvement of peripheral monocytes in several neurodegenerative diseases. Due to the different origins of these two cell types, it is important to distinguish their role and function in the development and progression of these diseases. In this review, we will summarize and discuss the current knowledge of the differential contributions of microglia and monocytes in the common neurodegenerative diseases AD, PD, and ALS, as well as multiple sclerosis, which is now regarded as a combination of inflammatory processes and neurodegeneration. Until recently, it has been challenging to differentiate microglia from monocytes, as there were no specific markers. Therefore, the recent identification of specific molecular signatures of both cell types will help to advance our understanding of their differential contribution in neurodegenerative diseases.

Entities:  

Keywords:  Microglia; Monocytes; Neurodegeneration; Neuroinflammation

Mesh:

Year:  2017        PMID: 29063348      PMCID: PMC7255107          DOI: 10.1007/s00702-017-1795-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  219 in total

1.  Sall1 is a transcriptional regulator defining microglia identity and function.

Authors:  Anne Buttgereit; Iva Lelios; Xueyang Yu; Melissa Vrohlings; Natalie R Krakoski; Emmanuel L Gautier; Ryuichi Nishinakamura; Burkhard Becher; Melanie Greter
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

2.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation.

Authors:  Hirohide Asai; Seiko Ikezu; Satoshi Tsunoda; Maria Medalla; Jennifer Luebke; Tarik Haydar; Benjamin Wolozin; Oleg Butovsky; Sebastian Kügler; Tsuneya Ikezu
Journal:  Nat Neurosci       Date:  2015-10-05       Impact factor: 24.884

3.  Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

Authors:  Oleg Butovsky; Mark P Jedrychowski; Ron Cialic; Susanne Krasemann; Gopal Murugaiyan; Zain Fanek; David J Greco; Pauline M Wu; Camille E Doykan; Olga Kiner; Robert J Lawson; Matthew P Frosch; Nathalie Pochet; Rachid El Fatimy; Anna M Krichevsky; Steven P Gygi; Hans Lassmann; James Berry; Merit E Cudkowicz; Howard L Weiner
Journal:  Ann Neurol       Date:  2014-11-27       Impact factor: 10.422

4.  Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.

Authors:  Manuel Rodriguez; Lydia Alvarez-Erviti; Francisco J Blesa; Maria C Rodríguez-Oroz; Ainhoa Arina; Ignacio Melero; Luís Isaac Ramos; Jose A Obeso
Journal:  Neurobiol Dis       Date:  2007-08-07       Impact factor: 5.996

5.  Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.

Authors:  Andrew D Greenhalgh; Rosmarini Passos Dos Santos; Juan Guillermo Zarruk; Christopher K Salmon; Antje Kroner; Samuel David
Journal:  Brain Behav Immun       Date:  2016-04-25       Impact factor: 7.217

6.  Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

Authors:  A L Ford; A L Goodsall; W F Hickey; J D Sedgwick
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

7.  Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.

Authors:  Jenny A Garcia; Paula A Pino; Makiko Mizutani; Sandra M Cardona; Israel F Charo; Richard M Ransohoff; Thomas G Forsthuber; Astrid E Cardona
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

8.  Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients.

Authors:  K Imamura; A Suzumura; F Hayashi; T Marunouchi
Journal:  Acta Neurol Scand       Date:  1993-04       Impact factor: 3.209

Review 9.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

10.  Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.

Authors:  Adrian Olmos-Alonso; Sjoerd T T Schetters; Sarmi Sri; Katharine Askew; Renzo Mancuso; Mariana Vargas-Caballero; Christian Holscher; V Hugh Perry; Diego Gomez-Nicola
Journal:  Brain       Date:  2016-01-08       Impact factor: 13.501

View more
  35 in total

1.  Neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives.

Authors:  Guillaume Dorothée
Journal:  J Neural Transm (Vienna)       Date:  2018-05       Impact factor: 3.575

2.  Histone Deacetylase 2 Inhibitor CAY10683 Alleviates Lipopolysaccharide Induced Neuroinflammation Through Attenuating TLR4/NF-κB Signaling Pathway.

Authors:  Fang-Zhou Jiao; Yao Wang; Hai-Yue Zhang; Wen-Bin Zhang; Lu-Wen Wang; Zuo-Jiong Gong
Journal:  Neurochem Res       Date:  2018-04-19       Impact factor: 3.996

Review 3.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

4.  A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury.

Authors:  Carmen Navarrete; Adela García-Martín; Alejandro Correa-Sáez; María E Prados; Francisco Fernández; Rafael Pineda; Massimiliano Mazzone; Marina Álvarez-Benito; Marco A Calzado; Eduardo Muñoz
Journal:  J Neuroinflammation       Date:  2022-07-09       Impact factor: 9.587

5.  Microglia Drive Pockets of Neuroinflammation in Middle Age.

Authors:  Eric N Moca; Daniela Lecca; Keenan T Hope; Fanny Etienne; Ari W Schaler; Katherine Espinoza; Megan S Chappell; Daniel T Gray; David Tweedie; Shanaya Sidhu; Lindsay Masukawa; Hannah Sitoy; Rose Mathew; Daniel R Saban; Nigel H Greig; Lindsay M De Biase
Journal:  J Neurosci       Date:  2022-04-08       Impact factor: 6.709

6.  Functional Analysis of Brain-Engrafted Monocytes After Microglia Ablation in Mouse Models.

Authors:  Nicholas H Varvel; Richard M Ransohoff; Jonas J Neher
Journal:  Methods Mol Biol       Date:  2019

Review 7.  Microglia as therapeutic targets after neurological injury: strategy for cell therapy.

Authors:  M Collins Scott; Supinder S Bedi; Scott D Olson; Candice M Sears; Charles S Cox
Journal:  Expert Opin Ther Targets       Date:  2021-06-01       Impact factor: 6.902

8.  Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers.

Authors:  Vlad Dionisie; Gabriela Adriana Filip; Mihnea Costin Manea; Robert Constantin Movileanu; Emanuel Moisa; Mirela Manea; Sorin Riga; Adela Magdalena Ciobanu
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 9.  Report on the National Eye Institute's Audacious Goals Initiative: Creating a Cellular Environment for Neuroregeneration.

Authors:  Marie E Burns; Beth Stevens
Journal:  eNeuro       Date:  2018-04-18

Review 10.  The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker.

Authors:  Yudie Yan; Jingtong Su; Zhen Zhang
Journal:  Cell Mol Neurobiol       Date:  2021-06-12       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.